Half of pharma execs are bracing for significant revenue impact from Medicare price negotiations this year, compared to just 22% in 2023, according to research 7 May 2024
A new age of innovation in immunology could change medical practice and people’s lives, as long as all parts of the system learn, evolve and work together, writ 1 May 2024
Interpharma, the association of research-based pharmaceutical companies in Switzerland, has called on lawmakers to reconsider a cost containment package which i 29 April 2024
Menarini Stemline has welcomed the publication of final draft guidance from the National Institute for Health and Care Excellence (NICE) recommending the use of 22 April 2024
Former Italian Prime Minister Enrico Letta has stressed the importance of access to medicines in a report on what is next for Europe’s single market. 19 April 2024
Bulgaria’s Supreme Administrative Court has cancelled the mechanism guaranteeing the predictability and sustainability of the National Health Insurance Fund (NH 15 April 2024
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.